[go: up one dir, main page]

FR3029411B1 - Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine - Google Patents

Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine Download PDF

Info

Publication number
FR3029411B1
FR3029411B1 FR1461913A FR1461913A FR3029411B1 FR 3029411 B1 FR3029411 B1 FR 3029411B1 FR 1461913 A FR1461913 A FR 1461913A FR 1461913 A FR1461913 A FR 1461913A FR 3029411 B1 FR3029411 B1 FR 3029411B1
Authority
FR
France
Prior art keywords
butanediol
esters
amino acid
human skin
skin lightening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1461913A
Other languages
English (en)
Other versions
FR3029411A1 (fr
Inventor
Laetitia Cattuzzato
Sandy Dumont
Jerome Guilbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR1461913A priority Critical patent/FR3029411B1/fr
Publication of FR3029411A1 publication Critical patent/FR3029411A1/fr
Application granted granted Critical
Publication of FR3029411B1 publication Critical patent/FR3029411B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
FR1461913A 2014-12-04 2014-12-04 Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine Active FR3029411B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1461913A FR3029411B1 (fr) 2014-12-04 2014-12-04 Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1461913A FR3029411B1 (fr) 2014-12-04 2014-12-04 Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine
FR1461913 2014-12-04

Publications (2)

Publication Number Publication Date
FR3029411A1 FR3029411A1 (fr) 2016-06-10
FR3029411B1 true FR3029411B1 (fr) 2018-03-02

Family

ID=52469135

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461913A Active FR3029411B1 (fr) 2014-12-04 2014-12-04 Utilisation d'esters avec le 1,3-butanediol de derives n-acyles d'acide amines, comme agent eclaircissant de la peau humaine

Country Status (1)

Country Link
FR (1) FR3029411B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066195B1 (fr) * 2017-05-12 2019-06-07 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Procede de synthese d'un compose n-acyle sans utiliser de solvant organique ni de chlorure d'acide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68916197T2 (de) * 1988-03-30 1994-09-29 Univ Boston Zusammensetzung zur in-vivo bzw. in-vitro steigerung des melaningehaltes der melanocyten und deren in-vitro verwendung.
FR2936152B1 (fr) * 2008-09-24 2010-11-12 Seppic Sa Monoglyceride de n-undecylenoyl phenylalanine, procede pour sa preparation et utilisation d'esters glyceriques de n-undecylenoyl phenylalanine comme agent eclaircissant la peau.
FR2981932B1 (fr) * 2011-10-27 2014-10-31 Seppic Sa Nouveaux esters de derives n-acyles d'acides amines et de diols, procede pour leur preparation, et utilisation en cosmetique et comme medicament

Also Published As

Publication number Publication date
FR3029411A1 (fr) 2016-06-10

Similar Documents

Publication Publication Date Title
HUS2300009I1 (hu) Karbidopa és L-dopa prodrogok és alkalmazásuk Parkinson-kór kezelésére
ECSP17078433A (es) Composiciones de ácido obeticólico y métodos de uso
EP3174874A4 (fr) Sels de berbérine, sels ursodésoxycholiques et des combinaisons, des procédés de préparation et d'application correspondants
DK3334422T3 (da) Anvendelse af cannabidiolsyre i behandling af epilepsi
MA41031A (fr) Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
HUE053946T2 (hu) 4'-Fluor-nukleozidok, 4'-fluor-nukleotidok és analógjaik HCV kezelésére
EP3271352A4 (fr) Carbamates de pipérazine et procédés de préparation et d'utilisation de ceux-ci
PL3145522T3 (pl) Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom
MA53108A (fr) Utilisation de prg4 comme agent anti-inflammatoire
DK3169232T3 (da) Intermitterende måling af partialtrykket af en analyt i hudvæv
EP2967836A4 (fr) Cryoconservation de substituts de peau humaine viables
PT4129270T (pt) Formulações de aminoácidos administradas por via oral de libertação modificada
MX2017006953A (es) Medicamentos para disminuir la evolucion de la enfermedad de parkinson.
EP3352771A4 (fr) Compositions de tissu ombilical et procédés d'utilisation
MA40759A (fr) Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
EP3399957A4 (fr) Compositions de raffermissement de la peau
MA43730A (fr) Malassezine et analogues correspondants en tant qu'agents d'éclaircissement de la peau
LT3151853T (lt) Glutamo rūgšties dekarboksilazė (gad), skirta panaudoti autoimuninės ligos gydyme
EP2950779A4 (fr) Procédés de blanchiment de la peau par utilisation d'extraits de canola
FR3027518B1 (fr) Utilisation d'ester d'isosorbide et de derives n-acyles d'acides amines comme agent antivieillissement de la peau humaine
MA41377A (fr) Gel intestinal de lévodopa et de carbidona et procédés d'utilisation
FR3023477B1 (fr) Utilisation cosmetique de l'acide spiculisporique comme actif deodorant
EP2934184A4 (fr) Compositions de xanthophylle et leurs procédés d'utilisation
EP2830608A4 (fr) Dérivés de phénylurée et de phénylcarbamate comme inhibiteurs d'agrégation de protéine
EP3395324A4 (fr) Agent anti-vieillissement et composition anti-vieillissement pour la peau

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160610

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12